#USA #New York #Class Action #Gross Law Firm #LifeMD

LifeMD, Inc. Faces Securities Fraud Class Action

The Gross Law Firm has announced that a class action lawsuit involving LifeMD, Inc. (NASDAQ: LFMD) is in progress, potentially impacting numerous shareholders. This lawsuit arises from allegations of securities fraud, and shareholders who purchased shares during the specified class period are encouraged to take action before the looming deadline of October 25, 2025.

Background and Allegations

According to the firm, the allegations focus on statements made by LifeMD's management that significantly misrepresented the company's competitive position in the health tech market. The complaint asserts that, during the defined class period from May 7, 2025, to August 5, 2025, the defendants issued materially false and misleading statements concerning the performance and guidance of LifeMD. Specifically, these statements failed to disclose several critical factors:

1. Overstated Competitive Position: LifeMD’s leadership is said to have exaggerated their competitive stance, significantly misleading investors about the company's market position.
2. Inaccurate Financial Guidance: The management's optimistic financial projections for 2025 did not adequately account for increasing customer acquisition costs. This miscalculation particularly applied to the RexMD segment, as well as costs associated with obesity treatment drugs like Wegovy and Zepbound.
3. Misleading Statements: As a result of these inflated claims and omissions, investors were led to believe that LifeMD's business operations and future prospects were more favorable than they truly were.

These allegations, if proven true, could result in significant financial repercussions for the involved parties and restitution for affected shareholders.

Actions Required by Shareholders

The Gross Law Firm is encouraging investors who bought shares of LFMD during the stated period to register their details as soon as possible. By doing so, they can secure their rights and potentially be appointed as lead plaintiffs. However, it’s important to note that appointment as a lead plaintiff is not necessary to participate in any recovery process.

Shareholders can easily register their details through the law firm's official website, ensuring they stay informed with real-time status updates about the case.

Looking ahead, shareholders will benefit from a portfolio monitoring service provided by the law firm. This service will allow them to track the progress of the class action throughout its lifecycle without any cost or obligation on their part.

The Importance of Legal Representation

Why should investors choose to work with The Gross Law Firm? The firm boasts a national presence and reputation for its relentless advocacy on behalf of investors facing deceit and fraud in the markets. Their commitment to responsible corporate practices and transparency makes them a formidable ally in the fight for shareholder rights. The firm’s record demonstrates a consistent pursuit of justice for individuals affected by false information or misconduct.

To ensure their voices are heard and to seek reimbursement for their losses, investors need to act swiftly in registering for the class action lawsuit. The deadline of October 25, 2025, is crucial and serves as a cutoff for participation. Failure to register by this date may forfeit their opportunity to recover potential damages resulting from the alleged fraud.

Conclusion

In conclusion, shareholders of LifeMD, Inc. facing losses during the class action period from May 7, 2025, to August 5, 2025, should not hesitate to contact The Gross Law Firm. This lawsuit represents not only an avenue for potential recovery but also a significant step towards accountability for the corporate misrepresentation that may have impacted many investors. For further details, shareholders can visit the Gross Law Firm's website or directly reach out via the provided contact information.